Bayamban, Eto H.
HRN: 22-57-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/02/2025
05/09/2025
IV
1.5 Gram
Q12 Hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes